Functional rather than immunoreactive levels of IgG₄ correlate closely with clinical response to grass pollen immunotherapy

Abstract

Functional assays of inhibitory IgG(4) and IgE-blocking factor may be more useful surrogates of clinical response than IgG(4). Whether these antibody effects may serve as predictive biomarkers of clinical efficacy in individual patients requires further investigation.